Business Context and Reporting Period
This Form 8-K was filed by Relmada Therapeutics, Inc. (formerly Camp Nine, Inc.) on July 14, 2014, reporting events occurring on July 8, 2014. The company is incorporated in Nevada and maintains its principal executive offices in New York, NY.
Key Financial Metrics
This filing is a current report regarding a corporate name change and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Corporate Name Change: Effective July 8, 2014, the company changed its name from Camp Nine, Inc. to Relmada Therapeutics, Inc. pursuant to a Certificate of Amendment to Articles of Incorporation filed with the State of Nevada.
- Symbol Change: The company indicated that the next step involves seeking FINRA approval to change its trading symbol to match the new corporate name.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or a discussion of risks and contingencies. The primary focus is the administrative execution of the name change.
Investor Verification Checklist
- Confirm the new trading symbol with FINRA and the relevant stock exchange.
- Review the attached press release (Exhibit 99.1) for strategic rationale behind the rebranding.
- Verify the updated corporate name in subsequent filings and regulatory databases.